ClinConnect ClinConnect Logo
Search / Trial NCT06740994

Ultrasound Guided Midline vs Landmark Paramedian Continous Spinal Anesthesia in the Elderly

Launched by UNIVERSITY TUNIS EL MANAR · Dec 17, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods of giving spinal anesthesia to elderly patients who are having surgery for hip fractures. Spinal anesthesia is a way to numb the lower half of the body, and this study aims to find out if using ultrasound to guide the anesthesia (the "modern" method) is better and safer than the traditional method that relies on the doctor feeling for landmarks on the body (the "blind" method).

To participate, patients need to be over 65 years old and scheduled for hip fracture surgery. They should also be in generally good health, as determined by a standard classification used by anesthesiologists. Patients who have certain health issues or previous back surgeries may not be eligible. Those who join the study will be randomly assigned to one of the two methods of anesthesia. Throughout the trial, participants can expect to receive care and monitoring just like they would in a regular surgery setting, with the goal of improving safety and effectiveness for future patients.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • all consented patients aged over 65 years old scheduled to undergo surgery for hip fracture under continuous spinal anesthesia with American Society of Anesthesiologists ASA physical status classification from I to III
  • Exclusion Criteria:
  • contraindications to spinal anesthesia ( allergy to local anesthetic, coagulopathy, infection at the site of injection)
  • previous history of lumbar spine surgery
  • per operative severe complication with conversion to general anesthesia

About University Tunis El Manar

The University of Tunis El Manar is a prestigious academic institution dedicated to advancing research and education in the medical and health sciences. As a clinical trial sponsor, it plays a pivotal role in fostering innovative research initiatives aimed at improving patient care and outcomes. The university collaborates with leading researchers and healthcare professionals to design and implement rigorous clinical studies that adhere to the highest ethical and regulatory standards. Through its commitment to scientific excellence and community health, the University of Tunis El Manar seeks to contribute valuable insights to the global medical field and enhance the quality of life in the region.

Locations

Nabeul, Mrazga, Tunisia

Patients applied

0 patients applied

Trial Officials

MECHAAL BEN ALI, Professor

Principal Investigator

university manar Tunis, Tunisia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported